Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Real Time & Level II Data
Showcase Companies
DealRoom
News Focus
Discover the Company Revolutionizing Casino Gaming (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Fennec Pharmaceuticals Ord Shs
T.FRX
Alternate Symbol(s):
FENC
Healthcare
Biotechnology
Fennec Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company, which is focused on its product candidate PEDMARK. The Company sells its product through a field force, including regional pediatric oncology specialists and medical science liaisons who are helping to educate the medical communities and patients about cisplatin induced ototoxicity and its programs supporting patient...
access to PEDMARK. PEDMARK is a Food and Drug Administration (FDA) approved therapy indicates to reduce the risk of ototoxicity associated with cisplatin treatment in pediatric patients with localized, non-metastatic and solid tumors. It is a formulation of sodium thiosulfate in single-dose, ready-to-use vials for intravenous use in pediatric patients. PEDMARK is a therapeutic agent with a dosing paradigm, across two open-label, randomized Phase III clinical studies, the Clinical Oncology Group (COG) Protocol ACCL0431 and SIOPEL 6.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:FRX)
New Post
View:
Posts & Comments
Threaded Posts
(61)
•••
willyk3
X
Comment by
willyk3
on Oct 17, 2022 8:41am
RE:Pedmark approved
Pedmark commercially available as of today!!! Great news for everyone involved..investors and patients alike.
(61)
•••
willyk3
X
Post by
willyk3
on Sep 21, 2022 8:24am
Pedmark approved
by the US FDA. Finally!!!! Now ....about that takeout??
Golden Investment Opportunity in Ghana and Canada
posted Oct 01, 2023 9:00am by
Pelangio Exploration Inc.
-
|
Pelangio’s recent agreement with TuNya provides a catalyst for exploration success at their Obuasi Project, a district-scale land package adjacent to the giant high-grade Obuasi mine. The agreement provides both exploration funding and access to a technical team with over 125 years of expertise on the extremely prolific Ashanti gold belt, including significant experience at the Obuasi mine itself, ...read more
(664)
•••
Betteryear2
X
Post by
Betteryear2
on Aug 01, 2022 10:14am
Fennec Pharmaceuticals Up to $45 M Investment From Petrichor
~ Under the Terms of the Investment Agreement, $5 Million to be Funded on initial closing and $20 Million to be Funded Upon Potential FDA Approval of PEDMARKTM ~ ~ Fennec Has the Potential to
...more
(61)
•••
willyk3
X
Comment by
willyk3
on Dec 13, 2021 8:05am
RE:RE:IS THIRD TIME THE CHARM FOR FENNEC PHARMACEUTICALS?
The obvious solution at this stage is to just sell the darn company (at a discount) to a real pharmaceautical company who has the capability to complete the process
(61)
•••
willyk3
X
Comment by
willyk3
on Dec 09, 2021 9:46am
RE:IS THIRD TIME THE CHARM FOR FENNEC PHARMACEUTICALS?
Absolute dud The fact that they failed at the manufacturing revisions shows that they and their mfg partner are incompetant at this aspect of the process. Wonder who that is ?
...more
(4)
•••
AviseAnalytics
X
Post by
AviseAnalytics
on Dec 09, 2021 7:08am
IS THIRD TIME THE CHARM FOR FENNEC PHARMACEUTICALS?
$FENC Fennec Pharmaceuticals (NASDAQ:FENC), a "specialty pharmaceutical company", received a CRL from the FDA for its New Drug Application (NDA) for PEDMARK™ (sodium
...more
(61)
•••
willyk3
X
Post by
willyk3
on Sep 27, 2021 5:30pm
11.50/18.00
Thats a heck of a spread on the bid ask? Has my machine gone bonkers?
(61)
•••
willyk3
X
Comment by
willyk3
on Jun 22, 2021 8:13am
RE:Times a wasting
Resubmission is in! Is there anyone out there to notice? Guess we still have to hope that they dont fail....with the FDA I am never confident of anything. Buyout coming???
(61)
•••
willyk3
X
Post by
willyk3
on Mar 20, 2021 12:49pm
Times a wasting
No news at all. Wonder whats up with that resubmission? Shouldnt financials be out for this quarter? I thought they were reasonably cashed up but lack of any communication from the company is
...more
(4)
•••
neuralProphet
X
Comment by
neuralProphet
on Mar 01, 2021 12:44pm
RE:Silent board
Not too may shares outstanding + less than avg 100k shares trading in CanadaUS in total = not enough retail owners to light up a Stockhouse board. Yahoo forum has a bit more action. Revenue wise
...more
(28)
•••
stockfy
X
Comment by
stockfy
on Jan 28, 2021 5:10pm
RE:Silent board
Any idea when FRX will report the first revenue? Just a rough estimate. Thanks.
(28)
•••
stockfy
X
Post by
stockfy
on Jan 28, 2021 5:09pm
Silent board
Why is this board so silent? Aren't any retail investors in FRX?
(1)
•••
JohnHintze48
X
Post by
JohnHintze48
on Sep 09, 2019 7:58am
Strategic Move at Fennec
ICYM l https://cutt.ly/3wPc78l
(5)
•••
alexmed95
X
Post by
alexmed95
on May 24, 2019 1:28pm
New here need informations
What's up everyone, i'm new here since i've came across FRX with this ATL and the pipeline it has. Looking for a good entry point but I need some breefing from you guys. Seems like people
...more
(61)
•••
willyk3
X
Post by
willyk3
on May 09, 2019 5:04pm
What the
Heck happened. I thot we were sposed to get a buyout at20+
Thank You
Your Report has been submitted.
Report Abusive Content
×
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Harness the Power: Elevate Your Understanding of Battery Metals & EVs - Free Insights Report Av alible
Energy Co. Announces Low Dilutive Development Capital Raise
Eminent Gold has signed a purchase & sale agreement with Orogen Royalties for property in Nevada